metabolic disease with pigmentary retinitis
ORPHA: 987131 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| L-carnitine Orphan | Oral tablets 330mg; oral solution 100mg/mL; IV injection 200mg/mL | FDA Approved, EMA Approved | 9 | 5d |
Classification & Codes
Orphanet Code
ORPHA:98713metabolic disease with pigmentary retinitis
| Orphanet | ORPHA:98713 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO